Are we cautious enough when we interpret results of randomized but underpowered comparisons?
- PMID: 16622279
- DOI: 10.1200/JCO.2005.04.9858
Are we cautious enough when we interpret results of randomized but underpowered comparisons?
Comment on
-
Bevacizumab in combination with fluorouracil and leucovorin: an active regimen for first-line metastatic colorectal cancer.J Clin Oncol. 2005 May 20;23(15):3502-8. doi: 10.1200/JCO.2005.10.017. J Clin Oncol. 2005. PMID: 15908660 Clinical Trial.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical